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Abstract
Background: To evaluate embryonic stem cell (ESC) harvesting methods with an emphasis on
derivation of ESC lines without feeder cells or sera. Using a murine model, laser-assisted blastocyst
dissection was performed and compared to conventional immunosurgery to assess a novel laser
application for inner cell mass (ICM) isolation.
Methods: Intact blastocysts or isolated ICMs generated in a standard mouse strain were plated in
medium with or without serum to compare ESC harvesting efficiency. ESC derivation was also
undertaken in a feeder cell-free culture system.
Results: Although ICM growth and dissociation was comparable irrespective of the media
components, an enhanced ESC harvest was observed in our serum-free medium (p < 0.01). ESC
harvest rate was not affected by ICM isolation technique but was attenuated in the feeder cell-free
group.
Conclusion: Achieving successful techniques for human ESC research is fundamentally dependent
on preliminary work using experimental animals. In this study, all experimentally developed ESC
lines manifested similar features to ESCs obtained from intact blastocysts in standard culture. Cell/
sera free murine ESC harvest and propagation are feasible procedures for an embryology
laboratory and await refinements for translation to human medical research.
Introduction
Embryonic stem cells (ESC) may be produced from the
inner cell mass (ICM) of intact blastocysts [1,2], by immu-
nosurgery [3,4], by other methods to isolate pluripotent
cells constituting the ICM [5] or single blastomeres [6,7].
Such techniques to derive ESC are easily reproduced in a
murine model, the mouse 129 strain being perhaps the
most commonly used experimental animal for this pur-
pose [1,5,8,9]. Indeed, this particular mouse model dem-
onstrates a number of desirable ICM features that make it
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growth, relatively large size, and a high content and per-
sistence of stem cells [10,11].
To be sure, the stem cells are not the only murine contri-
bution to ESC experimentation, as mouse embryonic
fibroblasts (MEF) also play a central supporting role in the
laboratory as feeder cells for ESCs [12,13]. However, a reli-
ance on cell/serum based mouse systems has underscored
some important limitations including possible xenogenic
or allogenic contamination [4]. Common immunosurgi-
cal methods for ICM isolation incorporate the use of allo-
genic antibodies and complement [3] which may also
introduce unwanted epitopes rendering some ESC deriva-
tives unsuitable for further applications.
Here we describe production of ESCs from blastocysts
obtained from a standard mouse strain in the absence of
feeder cells or sera, with an emphasis on a laser-based ICM
isolation modality. Additionally, the cells so harvested
met the morphological criteria and growth patterns
expected of ESCs as shown by specific molecular markers
and by gene expression analysis. Finally, to confirm the
ability of our ESC lines to provide the full range of differ-
entiated tissue types, the stem cells were induced to
develop into each of the three fetal germ layers.
Materials and methods
Specimens
B6D2-F1 (C57BL/6J  × DBA/2J ) mice were obtained
from Jackson Laboratory (Bar Harbor, ME, USA) and
Charles River Laboratories (Wilmington, MA, USA) and
housed at the Research Animal Resource Center of Weill
Medical College of Cornell University, in a temperature-
and light-controlled room on a 14 h light:10 h dark pho-
toperiod with food and water ad libitum.
Embryo collection, culture and media
Females (7–9 weeks) were superovulated with 10 IU of
pregnant mare's serum gonadotrophin (Sigma, St. Louis,
MO) then 10 IU of hCG (Sigma) 48 h apart. They were
next placed with males of the same strain and mating was
confirmed by presence of a vaginal plug the following
morning. Zygotes collected approximately 20 hours after
hCG were cultured in KSOMAA medium (Specialty Media,
Phillipsburg, NJ) at 37°C with 6% CO2 in humidified air.
Our ESC medium consisted of Dubelcco's Modified
Eagle's Medium (DMEM, Invitrogen, Carlsbad, CA, USA),
10% fetal bovine serum (FBS, HyClone, Logan, UT, USA),
and 10% newborn calf serum (NCS, HyClone) supple-
mented with mouse leukemia inhibitory factor (LIF,
2000IU/ml, Chemicon International, Temecula, CA), 0.1
mM nonessential amino acids (NEAA, Specialty Media),
0.1 mM β-mercaptoethanol (β-ME, Sigma), and 50 U/ml
penicillin/50 μg/ml streptomycin (Sigma). This investiga-
tion also utilized Knockout™ DMEM (Ko-M, Invitrogen)
with 15% Knockout ™ serum replacement (Ko-S, Invitro-
gen) containing LIF, NEAA, β-ME, antibiotics, and 4 mM
L-glutamine (Sigma) as the supplementary medium.
ESC harvesting
Feeder layers of mitomycin C-treated MEFs were prepared
on either 0.1% gelatin treated 4-well culture dishes (Nalge
Nunc International, Rochester, NY) or in 30 μl micro-
drops under oil in tissue culture dishes. Intact expanded
blastocysts (controls) and also zona-free blastocysts and
ICMs isolated after immunosurgery or microdissection
(see below), were plated onto MEF monolayers and cul-
tured in ESC medium in 6% CO2 at 37°C. Blastocysts
were observed every 24 h for hatching and attachment of
the trophoblast to a single MEF layer, while monitoring
ICM size in two dimensions. On day 4 or 5 after plating
(D4 or D5), ICM of at least 100 μm were dissociated using
a glass pipette, followed by trypsinization in PBS contain-
ing 250 U/ml trypsin and 1 mM EDTA (PBS-try-EDTA) to
promote cell dispersion. After re-plating in fresh wells
coated with feeder cells, ESC colonies developed in 2 or 3
days after which they were trypsinized and propagated by
passaging every 2–3 days thereafter. All established cell
lines were tested for mycoplasma using MycoAlert ™ Myc-
oplasma Detection Kit (Cambrex, Rockland, ME, USA).
ICM isolation
Intact blastocysts were plated onto feeder layers on post
fertilization day 4–5. Zona-free blastocysts were obtained
from incubation of day 4 blastocysts for 4–5 min in 24 U/
ml pronase (Sigma). These were washed x2 and cultured
for at least 1 h in medium with serum supplementation.
To obtain ICMs, zona-free blastocysts were incubated
with heat-inactivated rabbit anti-mouse serum (Sigma)
diluted with DMEM (Invitrogen) in 1:25 for 15 min then
exposed to guinea pig complement (Cedarlane laborato-
ries, Hornby, Ontario, Canada) at 1:10 dilution for 30
min in 6% CO2 in air at 37°C (Fig. 1). The disrupted tro-
phoblast was then removed by aspiration through a hand-
pulled 50–60 μm (inner diameter) pipette [3]. Laser-
assisted ICM isolation was performed as follows: Blasto-
cysts were secured by two holding pipette with the ICM
being positioned at 9 o'clock. Once adequate tension was
established, approximately 10 infrared laser pulses (300
mW × 1 ms, ZILOS-tk™, Hamilton Thorne Research, Bev-
erly, MA USA) were fired to split the blastocyst into two
unequal portions – the smaller consisting of ICM, the
larger consisting exclusively of trophoblast (Fig. 2).
Feeder cell-free culture and ESC characterization
The laser dissected ICM components were randomly
plated either on MEF feeder layer or directly on gelatin-
coated dishes, and cultured in Ko-M with 15% of Ko-S
(serum free) containing LIF, NEAA, β-ME, antibiotics, andPage 2 of 16
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were used as controls. ICM size was measured daily, ICM
dissociation and ESC propagation was carried out as
described earlier. Pluripotency was evaluated according to
cell size, nucleus/cytoplasm ratio, and nucleolar patterns.
ESC colonies were graded according to number, density,
and quality. Colony character was judged under an
inverted microscope equipped with phase-contrast optics
and stratified as follows: good (GG), average (GA), or
poor (GP) according to colony composition of >70%, 40–
70%, and <40% pluripotent cells, respectively (Fig. 3).
Typically, pluripotent cells are large and have a high
nucleus/cytoplasm ratio with one or more distinct nucle-
oli. DAPI banding was performed on metaphase chromo-
somes for ploidy assessment.
For this investigation, ESC pluripotency was determined
by two positive markers: alkaline phosphatase (AP) activ-
ity [8,14] and Oct-4 [15-18]. TROMA-1 monoclonal anti-
body (Ab) directed against cytokeratin-like filaments
present in trophectoderm and endodermal cells was used
as a negative marker [8,19-21]. All markers were tested on
control blastocysts. Specimens were fixed with 2% para-
formaldehyde (Sigma) and permeabilized with 0.5% Tri-
ton X-100 (Sigma). AP activity in fixed cells was detected
using an azo-dye technique with a Texas-Red filter under
fluorescence. The stain solution contained naphthol AS-
MX phosphate (Sigma) and fast red TR salt (Sigma) [22].
To detect expression of Oct-4 and TROMA-1, after incuba-
tion at 20°C for 60 min in 0.1% bovine serum albumin
(BSA, Sigma) and goat serum, ESCs were exposed to Oct-
4 polyclonal Ab (Santa Cruz Biotechnology, Santa Cruz,
CA) at 1:100 dilution and to monoclonal TROMA-1 Ab
(Developmental Studies hybridoma Bank, Iowa City, IA)
at 1:6 dilution. After rinsing unbound Abs with PBS/BSA,
specimens were next incubated with Alexa Fluor® 488
ImmunosurgeryFigure 1
Immunosurgery. Zona-free blastocyst (a) coated with rabbit anti-mouse antibodies. After addition of guinea pig comple-
ment, the outcome of unselective toxicity can be seen at t = 5 min (b), 15 min (c) and 30 min (d). Scale = 30 μm.Page 3 of 16
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con). The nuclei were counterstained with 0.125 μg/ml of
DAPI (Molecular Probes, Eugene, OR) in antifade solu-
tion or Topro-3 (Molecular Probes) at 1:500 dilution.
Specimens were examined via phase-contrast, fluorescent,
or laser confocal microscopy.
ESC gene expression
Pluripotency confirmation of putative ESCs was by mor-
phological criteria, specific molecular markers, and
expression of typical marker genes. Nanog (a divergent
homeodomain protein that directs propagation of undif-
ferentiated cells) is down-regulated during early de-differ-
entiation and becomes silent in completely differentiated
cells [23-25] while transthyretin (Ttr, a protein in visceral
yolk sac endoderm in vivo) [26-28] is expressed in differ-
entiated endoderm cells [29,30]. RNA was isolated from
ESCs by Absolutely RNA® Nanoprep Kit (Stratagene, La
Jolla, CA) with MEFs serving as a negative control. RNA
was stored at -80°C for qualification analysis. Primers
were custom-designed by OligoPerfect Designer software
(Invitrogen) for the target sequences of Nanog and Ttr
genes, while Act-β and Gapdh were used as normalizers.
Quantitative real-time PCR (qRT-PCR) was performed
using SuperScript™ III Platinum® Two-Step qRT-PCR Kit
with SYBR® Green (Invitrogen). Analysis was performed
using an ABI Prism 7900 HT (Applied Biosystems, Foster
City, CA). The qPCR results were plotted by the Sequence
Detection System Analysis Software (Version 2.0, Applied
Biosystems). Gene expression was reported as ratio data,
calculated from the cycle threshold against Act-β consid-
ered at 100% expression [31].
Laser dissectionFigure 2
Laser dissection. Blastocyst secured by two holding pipettes with inner cell mass (ICM) being positioned at 9 o'clock before 
(a) and after (b) being sectioned by laser with (b) and without (c) zona pellucida. Arrows (b, c) indicate the resected area by 
laser energy. The smaller blastocyst fragment (white arrow) contains the ICM while the larger (yellow arrow) is exclusively 
trophoblast (d). Scale = 30 μm.Page 4 of 16
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ESCs (n ~107) were subsequently treated with trypsin at
37°C in 5% CO2 for 5–7 min, resulting in detachment/
release of intact ESC colonies from underlying cells. Cell
aggregates of approximately 50–60 ESCs were placed in
20 μl hanging droplets (DMEM, 20% FBS, 2 mM L-
glutamine, 0.1 mM NEAA, antibiotics, and 1 mM β-ME)
on a 100 mm2 non-tissue culture lid flipped over a dish
containing 10 ml PBS. ESCs were cultured for two days to
allow aggregation into spheroid embryoid bodies (EBs).
On the third day EBs were transferred to a 60 mm bacteri-
ological petri dish in 5 ml of DMEM + 20% FCS, then after
two days placed in gelatin coated dishes for five days [32].
Differentiation into myocardiocytes was determined by
presence of pulsatile contractility at day 8–9 of culture, at
which point the EBs were processed for histological sec-
tions and transmission electron microscopy.
Determination of cellular differentiation
Induction of testicular teratoma formation was used to
assess differentiation capacity of experimental cell lines.
Approximately 1 to 4 × 106 undifferentiated cells were
injected into the testes of six- to eight- week-old severe
combined immunodeficiency (SCID) mice (C.B-Igh-1b/
IcrTac-Prkdcscid, Taconic, Germantown, NY, USA). Three to
five weeks later tumors were fixed in 4% paraformalde-
hyde, embedded in paraffin, and examined histologically
after hematoxylin and eosin staining.
Data analysis
A χ2 test was utilized for comparisons involving blastocyst
culture, attachment, ESC derivation, and gene expression
analysis. A two-tailed test was used to assess significance,
considered at 5% probability. Statistical comparisons
were reported in text and tables only when significance
was reached. Data tables show numbers within rows with
different superscripts as significantly different. All statisti-
cal computations were performed with StatView 512+
(BrainPower Inc., Calabasas, CA, USA).
Results
ESC harvest
In a series of experiments, 34 mated mice produced a total
of 613 zygotes, 566 (92.3%) of which developed to blast-
ocyst stage after four days of culture. Five preliminary
studies were performed in which 126 intact blastocysts
were plated on MEFs and cultured in DMEM supple-
mented with serum. Two days later, 82 (65.1%) ICMs had
hatched and attached to the feeder cell layer. On plating
day 5 (D5), 71 ICMs (56.3%) were successfully dissoci-
ated and replated, However, no ESC lines were estab-
lished. Optimal medium for murine ESCs was determined
from nine experiments where 126 intact blastocysts were
allocated to DMEM + 20% serum (Fig 4a–e) vs. Ko-M +
15% Ko-S (Table 1) (Fig.4f–j). In both media, over 60%
Grading embryonic stem cell coloniesFigure 3
Grading embryonic stem cell colonies. Examples of ESC 
classification into one of the three grades: Grade Good 
(GG), Average (GA), or Poor (GP). In GG colonies the area 
occupied by pluripotent cells is >70% of the entire colony (a). 
Approximately 60% of the colony is occupied by pluripotent 
cells in GA colonies (b), and a GP colony features only ~20% 
of pluripotent cells (c). Scale = 30 μm.Page 5 of 16
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ICM growth pattern as a function of mediaFigure 4
ICM growth pattern as a function of media. Inner cell mass (ICM) growth patterns of intact blastocysts in standard 
DMEM medium (a-e) and in knockout culture system (f-j). Intact blastocysts plated on feeder cells (a, f). ICM attachment and 
trophoblast outgrowth (b, g). Multilayer differentiation of ICM on day 5 (D5) after plating, note endodermal "rind" (c). Immedi-
ately after first dissociation (d, i) blastocysts cultured in standard DMEM failed to produce ESC colonies (e) and generated epi-
thelioid cells. In the knockout system, ICM growth showed negligible endodermal contamination (h) and after first dissociation 
with trypsin (red T bar) (i) generated ESC colonies (j). Scale = 50 μm.
Journal of Translational Medicine 2006, 4:20 http://www.translational-medicine.com/content/4/1/20of the plated blastocysts attached to the MEF layer and it
was possible to isolate between 20 to 30% of the ICMs.
While only 1 ESC line (1.6%) was harvested from the
standard DMEM system, 11 (17.5%) were obtained from
the Ko-M medium (p < 0.01). The culture carried out in
microdrops yielded comparable hatching and attachment
rates, although it facilitated easier monitoring of ICM
attachment and assessment of development than the 4-
well plate system. Although gelatin treatment was techni-
cally difficult for microdrop stabilization and positioning,
gelatinization of the area before preparation of the micro-
drop areas made this easier.
ICM isolation and ESC characterization
ICM attachment ability and consequent ESC colony har-
vest according to the different embryo manipulation
methods vs. control (n = 84) are depicted in Table 2. Zona
removal enhanced ICM attachment and became signifi-
cant (p < 0.05) when operative isolation of the ICM was
carried out. Embryo manipulation including operative
isolation of the ICM did not affect harvesting rate nor
quality and grading of ESC colonies. For these studies,
morphology was a consistent and reliable criterion for
evaluating ESC characteristics, the morphological charac-
teristics of stemness correlated closely with cell markers
and gene expression assays. A proportion of GG colonies
were not influenced by culture systems or ICM isolation
method. Colonies graded as GG had four normal male
and one female karyotype. All established ESC lines
remained euploid after several passages. Colony pluripo-
tency was confirmed by molecular markers. Outcomes
using AP and Oct-4 were in agreement (χ2 = 0.105) for
determining pluripotency of derived ESC lines. TROMA-1
served as a negative control for endodermal and trophob-
lastic cell contamination (Fig. 5). Pluripotency marker
assessment was concordant in all ESC colonies (Table 3).
Multimarker assay confirmed the ability of the morpho-
logical criteria and grading system to identify pluripotent
cells. We processed 10,000 to 30,000 cells to generate 0.3
to 0.9 μg of total RNA that displayed two ribosomal sub-
units. Reverse transcription and qRT-PCR were successful
in all cases. As expected, Nanog was expressed in 74.6% of
ESCs, but not in any MEFs. The latter manifested a higher
expression (69.6%, p = 0.0001) of Ttr (denoting differen-
tiation) compared to ESC colonies (40.7%).
Differentiation of cells
Using morphological determinants and molecular mark-
ers, at least 80% of ESC colony cells were undifferentiated.
Culture in the absence of feeder cells and LIF permitted
formation of tight, round aggregates. After day 2 of cul-
ture, a distinctive outer layer of endodermal cell differen-
tiation became apparent, each droplet containing a
spherical embryoid body of ~320 μm diameter (Fig. 6).
Reaching ~450 μm diameter by day 9 of culture, about
20% EBs displayed foci of pulsatile contraction typical of
cardiomyocyte differentiation (Fig. 6). Histology and
ultrastructural examination confirmed cell components of
primordial embryonic germ layers (Fig. 7). EBs cultured
for 16 days displayed widespread epithelial cell differenti-
Table 2: Influence of blastocyst manipulation on ICM attachment and ESC harvesting
Blastocyst manipulation methods
No. of (%) IC ZF IS LD
Blastocysts/ICM 25 14 24 21
Attached on MEF 17 (68.0)a 12 (85.7)a,b 24 (100)b 20 (95.2)b
First dissociation 6 (24.0) 3 (21.4) 9 (37.5) 9 (42.8)
ESC primary colonies 4 (16.0) 1 (7.1) 3 (12.5) 5 (23.8)
IC = Intact blastocyst, ZF = Zona-Free blastocyst, IS = Immunosurgery, LD = Laser dissection
a,bχ2, 2 × 4, 3 df, Effect of blastocyst manipulation on ICM attachment, (IC vs IS & LD), p < 0.05
Table 1: Intact blastocyst culture on MEF in different media
Embryonic day (d) Plating day (D) No. of (%) DMEM + 10%NCS, 10% FBS Ko-M + 15% Ko-S
d4 D0 Blastocysts (I) plated 63 63
d5–6 D1–2 Hatched blastocysts 53 (84.1)a 42 (66.7)b
d6–7 D2–3 Attached on MEF 51 (80.9) 42 (66.7)
d8–9 D4–5 ICM isolation 18 (28.6) 14 (22.2)
d14–16 D10–12 ESC primary colonies 1 (1.6)c 11 (17.5)d
FBS = fetal bovine serum, NCS = newborn calf serum, Ko-M = Knockout™ DMEM, Ko-S = Knockout™ serum replacement
a,bχ2, 2 × 2, 1 df, Effect of ESC medium on hatching rate, p < 0.05
c,dχ2, 2 × 2, 1 df, Effect of ESC medium on ESC derivation rate, p < 0.05Page 7 of 16
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between the EBs. Both simple and stratified epithelial cells
were present. Testes injected with ESCs uniformly devel-
oped tumors containing derivatives of all three embryonic
germ layers including mucus-producing columnar epithe-
lium, ciliated columnar epithelium, glandular epithelium
arranged in acini, endothelium lined vessels within intra-
luminal neutrophils, striated muscle, bone, cartilage, neu-
ral tissue (often forming rosettes), and keratinizing
epithelium (Fig. 8).
Localization of pluripotency markersFigure 5
Localization of pluripotency markers. Alkaline phosphatase (AP) activity (left), Oct-4 (center), and TROMA-1 (right) 
expression as measured in expanded and hatched blastocysts (top row, a-c), mouse embryonic fibroblasts (middle row, d-f) 
and embryonic stem cell colonies (bottom row, g-i) by immunofluorescent analysis. In left column, red signals indicate positive 
AP activity (a, g). In center, red signals identify positive Oct-4 expression (b, h) while the right column TROMA-1 expression is 
shown as green signals (c, hatched blastocyst). DAPI was used for nuclear DNA counterstaining as indicated by blue signals. 
Scale = 30 μm.Page 8 of 16
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Intact blastocysts (n = 131) were laser dissected and 65 of
these were plated on MEF with the remainder (n = 66) on
gelatin-coated dishes (Table 4). Laser dissection was suc-
cessful in all cases. In the absence of MEF, attachment of
ICM occurred at a similar rate than control (81.8% vs.
92.3%), and observed growth patterns were also compa-
rable. A total of 6 (9.1%) ESC lines was established on gel-
atin, while 15 (23.1%) on MEF. ESC harvest efficiency was
significantly higher on feeder cells (p < 0.05). Cell lines
Coalescence and development of embryoid bodiesFigure 6
Coalescence and development of embryoid bodies. Day 1: Aggregation of individual ESCs to form spherical bodies (EB 
= embryiod body). Day 3: EBs ranging from 100–250 μm mean diameter. Day 4: Growing EBs of ~350 μm. Day 9: An EB with 
a cystic structure. Day 17: EB with outgrowth and vesicular cavity.
Table 3: ESC marker expression in derived ESC lines
Stemness phenotype*
ESC line ID (Experiment# Blastocyst#) Blastocyst manipulation methods Initial grading AP activity‰ Oct-4™ TROMA-1∫
167 I Poor + + -
1634 I Average + + -
1635 I Good + + -
176 ZF Poor + + -
1713 IS Average + + -
* + and – indicate "positive" or "not detectable" activity or protein expression, respectively
†AP activity is positive marker for pluripotent cells
‡Oct-4, Octamer-binding transcriptional factor 4, is positive marker for pluripotent cells
∫ TROMA-1, trophectodermal monoclonal antibody, which reacts to keratin filaments in trophectodermal and endodermal cells, is assessed as a 
negative marker for pluripotent cellsPage 9 of 16
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pluripotency to the same degree as that observed in con-
trols
Discussion
As with any scientific investigation using animal models,
it is envisioned that experience gained from murine ESC
work will supply answers to challenges still vexing the
human ESC field. To be sure, the recent identification of
proteins and sialic acid residues on stem cell surfaces [33]
resulting from MEF contamination has redoubled the
need to develop methods to culture ESCs without feeder
cells, and further research is needed to derive ESC lines in
more controlled systems [8,13,34]. In our investigation
we obtained ESC lines without feeder layers and sera,
although the efficiency was lower than desired. These cell
lines demonstrated all ESC characteristics with respect to
morphology, marker expression, and differentiation capa-
bility both in vivo and in vitro. These results therefore rep-
resent a start along the way to establish ESC lines in
controlled and xenogenic by-product free culture condi-
tions.
The morphological grading method developed here
proved useful to characterize colonies as well as to moni-
tor pluripotent status of the cells, and was helpful to iden-
tify early differentiation. All cell lines obtained
experimentally demonstrated typical ES morphology via
light microscopy, staining strongly for alkaline phos-
phatase activity and expressing Oct-4 [13]. Molecular
markers such as Oct-4 [15,16] and Nanog expression
[23,24] are critical to confirm stemness because of their
role in pluripotency regulation and cellular self-renewal.
Assessment of trophoblastic markers such as TROMA-1
[19,20] and Ttr [26,27] supported cytometric grading in
our derived ESC lines. The development of embryoid bod-
ies was a further indicator that harvested cells retained the
ability to develop into the three embryonic disc compo-
Ultrastructure of embryoid bodiesFigure 7
Ultrastructure of embryoid bodies. Transmission electron microscopy of embryoid body showing three embryonic germ 
layers including keratin filaments (ectoderm), cardiomyocyte with contractile components (mesoderm), and microvilli (endo-
derm).Page 10 of 16
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cell lines gave rise to teratomas in vivo served to confirm
their pluripotency.
A recent study [35] described only a 2% rate of ESC deri-
vation using C57BL/6 mice, a model with a similar genetic
background compared to our B6D2-F1 (C57BL/6J × DBA/
2J) strain. Results from the present study are in general
agreement with those of previous reports [36,37] where
DMEM + serum was utilized, although substantially lower
than the 30% reported from the 129 strain [1]. The higher
ESC efficiency reported from the 129 strain may be due to
the fact that this is an inbred strain and is characterized by
the persistence of stem cells into adulthood [10], or, alter-
natively, because of absence of a PGC survival factor
[38,39]. In our experiments, ESC harvest was improved by
substituting a combination of serum free Ko-M + Ko-S
media [40], the beneficial effect of which may be ascribed
to the relatively low osmolarity and the absence of differ-
entiating factors present in bovine sera [36,41-43].
Reduced ESC harvesting following immunosurgery might
be explained by endodermal contamination (Fig. 9) and/
or persistence of trophoblastic cells as proven by the for-
mation of unilaminar vesicles (Fig. 10). Most ICMs iso-
lated by immunosurgery from day 5 blastocysts can
regenerate an external layer of endodermal cells once cul-
tured in vitro [44], offering further evidence that immuno-
surgery is not ideal for isolation of uncontaminated
epiblasts. As cytotoxic antibodies destroy all blastocyst
cell types, a less than perfect timing of exposure to such
reagents might result in escape of some endodermal cells
[44] allowing them to form the characteristic rind (Fig.
11).
Histology of teratoma induced by ESC injectionFigure 8
Histology of teratoma induced by ESC injection. Teratoma was induced by injection of ESC into SCID mouse testis. 
Ectodermal differentiation is observed with basophilic staining in a cord-like distribution, typical neural tissue organization (a1), 
and neuronal rosette (a1 inset). Squamous epithelium shows normal keratin deposition pattern (a2). Mesodermal components 
include cartilage (b1) and striated muscle (b2). Endodermal differentiation to a gut-like structure lined with mucinous epithe-
lium (c1). Cells organized in acinar structure typical of glands (pancreas or salivary) (c2).Page 11 of 16
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ductive technologies for several years, including assisted
hatching [45] embryo or polar body biopsy [46,47],
sperm immobilization [47], and ICSI [48], all of which
have resulted in successful pregnancies. In contrast to
immunosurgery where trophoblastic disruption depends
on bioactivity of antibodies and complements [49], laser
pulses can be precisely delivered to excise the ICM. Per-
haps more importantly, ICM isolation via laser energy
avoids xenogenic contamination by reagents and requires
minimal micromanipulation skills. Although operative
isolation of ICM did not translate to a higher proportion
of harvested ESCs in the present study (Table 2), identifi-
cation of other techniques to isolate ESC precursor cells
from ICM may reduce embryo wastage [7]. Among vari-
ous methods tested here, laser dissection seemed to opti-
mize ESC harvest. This observation is in general
agreement with previous work [5,50-59] where specific
ICM progenitors of stem cells were identified by disaggre-
gation of the epiblast under varied culture conditions. In
our studies, this approach yielded a higher ESC harvest
rate than that following intact blastocyst plating (52 vs.
23%, respectively). It is anticipated that additional
research will further optimize cell-free culture systems
[50,53].
Conclusion
In summary, this research illustrates that while a thorough
understanding of culture conditions is essential to
develop an effective general strategy for the efficient deri-
vation of mammalian ESC lines, this can be accomplished
in a routine embryology laboratory using a conventional
mouse strain and laser applications as described here.
Using B6D2-F1 mice we established 46 new ESC lines: one
via a standard DMEM medium, 16 with a 'knockout'
medium, and 29 derived after operative isolation of the
ICM – including 6 without feeder cells and serum. While
all lines were euploid, exhibited good morphology, and
maintained a high level of pluripotency when tested in
vitro, these results merit continued study to refine estab-
lishment of ESC lines from non-permissive mouse strains.
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Organization of primitive endodermFigure 9
Organization of primitive endoderm. Schematic of expanded blastocyst with absence (a) and presence (b) of primitive 
endoderm (hypoblast) in a day 4 expanded blastocyst and day 6 hatched blastocyst, respectively. In b, ICM remnant is defined 
as the epiblast (green) and the hypoblast (yellow). Hatching blastocyst (c) with epiblast (green arrow) and hypoblast (yellow 
arrow). Scale = 30 μm.
Table 4: ESC harvesting efficiency with or without feeder cell layers
No of (%) Feeder Without feeder
Isolated ICMs 65 66
Attached 60 (92.3) 54 (81.8)
First dissociation 27 (41.5) 21 (31.8)
ESC colonies 15 (23.1)a 6 (9.1)b
a,bχ2, 2 × 2, 1 df, Effect of feeder cell on ESC harvesting, p < 0.05Page 12 of 16
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Vesicle formation post-immunosurgeryFigur  10
Vesicle formation post-immunosurgery. Unilaminar vesicle generated from plated ICM after immunosurgery with obvi-
ous endodermal contamination at day 1 (a) and day 2 (b). Scale = 30 μm.
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Observed growth patterns according to ICM isolation techniqueFigure 11
Observed growth patterns according to ICM isolation technique. Attachment of ICM and trophectodermal out-
growth with large (b1, b2, after immunosurgery) or minimal (a1, a2, intact blastocyst) endodermal contamination. Such con-
tamination is completely absent following laser dissection (c1, c2). First column shown at 200×, second column shown at 400×. 
Scale = 50 μm.
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